4.7 Article

Forskolin Induces Endocrine Disturbance in Human JEG-3 Placental Cells

Journal

TOXICS
Volume 10, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/toxics10070355

Keywords

placenta; forskolin; endocrine disruptors; P2X7 receptor; hormones

Funding

  1. Adebiopharm ER67

Ask authors/readers for more resources

This study evaluated the placental toxicity of Forskolin in pregnant women. The results showed that Forskolin activated P2X7 receptors and disrupted the secretion of estradiol, progesterone, hPL, and hyperglycosylated hCG in placental cells. This suggests that Forskolin may pose risks to pregnant women and should be restricted.
Forskolin, used in folk medicine since ancient times, is now available as a dietary supplement, with an indication as a fat burner and appetite suppressant. However, the safety of forskolin is poorly documented especially for pregnant women. The question that we raised is what about the safety of forskolin in pregnant women? As the placenta, an endocrine organ, is the key organ of pregnancy, we evaluated the in vitro placental toxicity of forskolin. We focused first on the activation of a P2X7 degenerative receptor as a key biomarker for placental toxicity, and second on steroid and peptide hormonal secretion. We observed that forskolin activated P2X7 receptors and disturbed estradiol, progesterone, hPL and hyperglycosylated hCG secretion in human placental JEG-Tox cells. To the best of our knowledge, we highlighted, for the first time, that forskolin induced endocrine disturbance in placental cells. Forskolin does not appear to be a safe product for pregnant women and restrictions should be taken.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available